Doctor profile · Federal record

Dr. Theresa Popas, NP-C

Nurse Practitioner · Chattanooga, TN

  • NPI 1437589678
  • Accepts Medicare
  • 13 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
725 Glenwood Dr Ste E780
Chattanooga, TN 374041177
(423) 697-0072
fax (423) 697-1798

Credentials & registration

NPPES · NUCC
NPI registered
November 2013 — 13 yrs on file
Profile last updated
April 22, 2025
Year of graduation
2013 — 13 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
Tennessee #18128

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1437589678. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
898
Distinct HCPCS
6
Medicare allowed
$73,968
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 340 162 $99
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 226 126 $107
80307 Testing for presence of drug, by chemistry analyzers 202 117 $58
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 53 53 $28
99213 Established patient office or other outpatient visit, 20-29 minutes 42 37 $66
G0444 Annual depression screening, 5 to 15 minutes 35 35 $14

In context: peer comparison

Among 55 peers in Chattanooga Nurse Practitioner, average services per provider: 139. This provider delivers 6.5× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,005
Transactions
44
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Sumitomo Pharma America, INC. 12 $202.48
Urogen Pharma, INC. 7 $145.16
Abbvie INC. 6 $96.34
Merck Sharp & Dohme LLC 3 $72.73
Boston Scientific Corporation 2 $43.34
Accord Healthcare, INC. 2 $43.16
AngioDynamics, INC. 2 $39.88
ConvaTec INC. 2 $32.59
Protega Pharmaceutials INC 1 $32.18
Saluda Medical Americas, INC. 2 $29.68
Tolmar, INC. 1 $28.40
Procept BioRobotics Corporation 1 $23.93
Endo USA, INC. 1 $23.48
Myriad Genetic Laboratories, INC. 1 $23.08
Salix Pharmaceuticals, A Division of Bausch Health US, LLC 1 $20.34

By nature of payment

Food and Beverage
$1,005

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
6,567
Patients
1,653
Total drug cost
$449,367
Drug Type Claims Patients Total cost
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 1,384 246 $43,008
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 1,383 266 $39,024
Gabapentin Generic 942 250 $21,163
Pregabalin Generic 424 126 $19,146
Oxycodone Hcl Generic 368 78 $6,981
Tizanidine Hcl Generic 308 89 $5,848
Belbuca (Buprenorphine Hcl) Brand 277 56 $243,533
Methocarbamol Generic 232 74 $5,287
Morphine Sulfate ER (Morphine Sulfate) Brand 219 41 $5,333
Cyclobenzaprine Hcl Generic 217 72 $2,871

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Theresa Popas's medical specialty?
Dr. Theresa Popas practices Nurse Practitioner in Chattanooga, TN.
Where does Dr. Theresa Popas practice?
Dr. Theresa Popas practices at 725 Glenwood Dr Ste E780, Chattanooga, TN 374041177. Office phone: 4236970072.
What is Dr. Theresa Popas's NPI?
Dr. Theresa Popas's National Provider Identifier (NPI) is 1437589678, issued by NPPES.
Does Dr. Theresa Popas accept Medicare assignment?
Yes. Dr. Theresa Popas accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Theresa Popas commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS G0480); Testing for presence of drug, by chemistry analyzers (HCPCS 80307). Source: CMS Medicare Physician & Other Practitioners file.